https://science37.com

Science 37 | One Site. Any Patient. Total AccessScience 37 expands trial access, reaching a new and more diverse patient population. Deliver patient-friendly hybrid and decentralized clinical trials, with clinical research that works for everyone.,The Virtual Clinical Trial Direct-to-Patient Site—DCT and Hybrid ResearchScience 37 | One Site. Any Patient. Total Access Participate in a StudyWhat We Do Direct-to-Patient Site Patient Recruitment Research-Grade Nursing Case Studies Who We Are About Us Investigators News Resources Careers Events Contact Us hello world! One Site. Any Patient.Total Access.Science 37 is the industry-leading patient access company dedicated to supporting clinical trial enrollment through patient-and site-centric solutions.The First & OnlyFDA-InspectedDirect-to-Patient SiteDirect-to-Patient SiteAccess 100% of your target population with the industry's only FDA-Inspected Direct-to-Patient SiteBy bringing clinical research to the patients’ home with high quality care and the detailed execution, delivery, and data collection you expect from your best sites.Learn More About Our Quality-Focused SitePatient RecruitmentResults-based patient enrollmentMedical record-qualified, site-ready referrals that reduce site burden and accelerate randomization.See How Our Recruitment Drives Faster EnrollmentResearch-Grade NursingAlways high-qualityAlways our employeesOur team of 150+ research-grade nurses, trained and certified by our investigators, ensure exceptional delivery of clinical assessments and procedures, every time.Discover How Our Nurses Enhance Your Trialhello world!One Site. Any Patient.Total Access.Science 37 is the industry-leading patient access company dedicated to supporting clinical trial enrollment through patient-and site-centric solutions.The First & OnlyFDA-InspectedDirect-to-Patient SiteDirect-to-Patient SiteAccess 100% of your target population with the industry's only FDA-Inspected Direct-to-Patient SiteBy bringing clinical research to the patients’ home with high quality care and the detailed execution, delivery, and data collection you expect from your best sites.Learn More About Our Quality-Focused SitePatient RecruitmentResults-based patient enrollmentMedical record-qualified, site-ready referrals that reduce site burden and accelerate randomization.See How Our Recruitment Drives Faster EnrollmentResearch-Grade NursingAlways high-qualityAlways our employeesOur team of 150+ research-grade nurses, trained and certified by our investigators, ensure exceptional delivery of clinical assessments and procedures, every time.Discover How Our Nurses Enhance Your Trialhello world!Top NewsScience 37 Appoints Kelly Johnston McKee as VP of Strategy & Transformation 1 2 3 … 126 Next » Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards 1 2 3 … 126 Next » Science 37 Receives 2025 Clinical Trials Arena Site Innovation Award for R&D Leadership 1 2 3 … 126 Next » Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial  1 2 3 … 126 Next » hello world!Science 37 is a clinical research site that delivers trials directly to patients' homes. The First & OnlyFDA-Inspected Direct-to-Patient SiteThe First & OnlyFDA-InspectedDirect-to-Patient SiteFive Phase 3 Trials Inspected:No Action Indicated (NAI) classificationNo objectionable conditions notedNo Form 483 issuedNo recommendationsRead About Our Latest InspectionScience 37 was founded more than a decade ago by investigators with the vision to make clinical research accessible to anyone, anywhere, anytime, regardless of their proximity to research sites.We carry that vision forward through the expertise of world-class clinical research professionals who develop customized solutions that help patients discover, qualify for, and participate in studies—regardless of their social determinants of health. Redefining Clinical Trial Participation:Proven, Inspected, and Trusted.Top 1% ofEnrolling SitesRanked as the leading enroller on  >50% of our trials.The First & OnlyFDA-InspectedDirect-to-Patient SiteFive Phase 3 trials inspected, resulting in an NAI classification.185+ TrialsSupportedTherapeutic area agnostic.A Look at Our Enrollment Performance.Our contribution to enrollment is often among the highest across study sites.NarcolepsyPhase 455%of total study participantsFDA InspectedAsthmaPhase 3, Pivotal28%of total study participantsFragile X SyndromePhase 325%of total study participantsCOVID-19 ProphylaxisPhase 342%of total study participantsFDA InspectedColorectal Cancer Prevention, Pivotal49%of total study participantsCholestatic PruritusPhase 221%of total study participantsFDA InspectedPrimary Biliary CholangitisPhase 3, Pivotal47%of total U.S. study participantsVascular Ehlers-DanlosSyndrome Phase 3100%of total study participantsView Our Case StudiesPatients are more than just a number.They want to participate on their terms.Patients are more than just a number. They want to participate on their terms.For Trial Sponsors: Expand access. Enhance diversity. Optimize enrollment.Science 37’s Direct-to-Patient Site expands your trial’s reach beyond the geographic limits of traditional sites. With nationwide recruitment, our site delivers broader patient access and faster enrollment. From simple to complex studies, our experienced team of investigators, research-grade nurses, and CRCs brings the full-site experience directly to the patient’s home.Optimize Your Trial EnrollmentFor Patients: Participation, on your terms.Life moves quickly—participating in research should keep up. Join clinical trials from anywhere, with no barriers of location, scheduling, or inconvenience. Whether it's from your living room or while you're traveling, our dedicated, experienced and highly trained nurses are with you every step of the way, ensuring a seamless experience no matter where life takes you.Participate in a StudyFPOSome of Our Partners.Just some of the incredible partners powering our mission to bring clinical research to patients.Acer TherapeuticsAdrenasAdvarraAnthos TherapeuticsAutoCruitmentAvillionBayerBiohavenBoehringer IngelheimCatalentChugai PharmaceuticalDelfiEscient PharmaceuticalsGSKHarmony BiosciencesJazz PharmaceuticalsLabConnectMirum PharmaceuticalsPureTech HealthRxE2Jonathan Cotliar, MDDebra Weinstein, MDThe industry's most experienceddirect-to-patient, hybrid, and virtualtrial investigators.Meet Our Broadly-Licensed PhysiciansWe're actively recruiting and enrolling patients across a range of therapeutic trials.CardiovascularCNSDermatologyEndocrinologyGastroenterologyHematologyImmunologyInfectious DiseaseMen’s HealthMusculoskeletalOncologyOphthalmologyRespiratoryUrologyWomen’s HealthSee Our Enrolling StudiesTrusted by Sponsors. Loved by Patients."Science 37’s innovative services meant we could bring the trial to the homes or neighborhoods of patients in rural areas who would typically have to travel hundreds of miles to the nearest clinical site, which may otherwise have been a barrier to participating..."–Brandon Maggio, Global Head of Digital Operations & Process Optimization, GSKMore On Our Partnership with GSK"The people involved in the trial make all the difference. Especially in an oncology trial where a nurse comes into your home for two hours at a time; it means a lot if they’re personable and you don’t feel like you’re being treated like a statistic, you’re being treated like a human."–Study ParticipantRead the Full Patient StoryConnect with our team to explore how we canenhance patient access and enrollment for your trial.Connect with our team to explore how we can enhance patient access and enrollment for your trial. Privacy & ConsentPrivacy PolicyCookies Notice & ConsentMobile Privacy PolicyTerms & ConditionsSMS Texting Terms & ConditionsConsumer Health Privacy NoticePrivacy ChoicesWhat We DoDirect-to-Patient SitePatient RecruitmentResearch-Grade NursingCase StudiesWho We AreAbout UsInvestigatorsNewsResourcesCareersEventsContact UsParticipate in a Study© 2026 Science 37 | All Rights Reserved arrow-rightlinkedinenusen-US1772907374https://science37.com

Edit your site?

What are you doing?